Navigation Links
Xarelto Lawsuits Filed Contend Wrongful Death and Internal Hemorrhaging Due to Blood Thinner
Date:7/20/2014

Columbus, OH (PRWEB) July 20, 2014

The attorneys at Wright & Schulte LLC have learned through Reuters that almost 10 Xarelto lawsuits have been filed in the United States against Germany-based Bayer AG over its blood-thinning medication. Court records indicate that one of the Xarelto lawsuits was filed on behalf of a Kentucky woman who alleges developing uncontrollable internal bleeding as a result of taking the blood thinner. The Xarelto lawsuit was filed February 24 in the Pennsylvania Court of Common Pleas, Philadelphia County. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) More recently, a Florida woman filed a Xarelto wrongful death complaint in the U.S. District Court, Southern District of Florida that alleges her husband died due to uncontrollable bleeding after taking Xarelto. (Case 9:14cv80831)
[reuters.com/article/2014/06/14/us-bayer-
suit-idUSKBN0EP0HW20140614, June 14, 2014]

Xarelto, generically known as rivaroxaban, is a prescription blood thinner manufactured by Bayer and marketed in the United States by Janssen Pharmaceuticals, a division of Johnson & Johnson. The U.S. Food & Drug Administration (FDA) approved Xarelto for treatment in reducing deep vein thrombosis and pulmonary embolism in patients who had knee or hip replacement surgery and for reducing stroke and blood clot risks in patients with atrial fibrillation.
[fda.gov/NewsEvents/Newsroom/Press
Announcements/ucm326654.htm, November 2, 2012]

According to court documents, a Florida woman filed a Xarelto wrongful death complaint on June 23, 2014, in U.S. District Court, Southern District of Florida that alleges her husband was prescribed Xarelto in January 2012 to treat atrial fibrillation. According to the Xarelto lawsuit, the spouse was hospitalized on June 23, 2012, after suffering a subdural hemorrhage. He underwent a medical procedure in an attempt to stop the bleeding, but died five days later. The Florida woman’s Xarelto lawsuit contends that the defendants, Janssen Research & Development and Bayer, concealed their knowledge to consumers, the general public and the medical community that Xarelto allegedly causes life-threatening irreversible bleeds. The Xarelto lawsuit further contends the defendants did not warn or advise how to intervene and stabilize a patient should a bleed occur. (Case 9:14cv80831)

Court records further show that a Kentucky woman’s Xarelto complaint against Janssen Research & Development and Bayer Corp. alleges she was prescribed the blood thinner in July 2012 to treat atrial fibrillation. In February 2013, she suffered severe internal and gastrointestinal bleeding that required hospitalization in order for doctors to stop the bleeding. The Xarelto complaint further alleges that the defendants were negligent in introducing the drug. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754) The complaint was filed a month after the Pennsylvania Supreme Court’s January 21st ruling that pharmaceutical companies in Pennsylvania can be held negligent for marketing or designing drugs that they know or should have known are to dangerous to use.
[pacourts.us/assets/opinions/Supreme/out/J-69AandB-2011mo.pdf?cb=7, January 21, 2014.]

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you or your loved one suffered serious internal bleeding or other related complications as a result of using Xarelto, contact the law firm for a free, no-obligation legal consultation. If you're looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029984.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
2. Xarelto is Alleged to Cause Serious and Uncontrolled Internal Bleeding
3. Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
4. AffordRx Now Offering Xarelto Coupon Cards
5. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
6. Federal DePuy ASR Litigation Schedules July Conference to Discuss Lawsuits over Recalled Hip Replacement
7. Nearly 780 Mirena IUD Lawsuits Now Filed in New Jersey Litigation, Bernstein Liebhard LLP Reports
8. As Testosterone Lawsuits Are Filed In The U.S., Canada Warns of Possible Cardiac Risks Associated With Testosterone Medication
9. Stryker Recall Litigation in New Jersey Now Includes More than 2,000 Lawsuits over Rejuvenate, ABG II Metal Hips, Bernstein Liebhard LLP Reports
10. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
11. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2016)... ... February 14, 2016 , ... Many eating ... professionals near their residence. The nature of the illnesses requires ongoing supervision, therapy ... time allotted at work to make traditional appointments. These people struggle to maintain ...
(Date:2/13/2016)... ... February 13, 2016 , ... Good news for retinal patients ... area to offer AngioPlex™ Optical Coherence Tomography (OCT) Angiography, imaging technology used to ... diabetic retinopathy, and other vascular conditions. , In just a few seconds, OCT ...
(Date:2/13/2016)... Angeles, California (PRWEB) , ... February 13, 2016 , ... ... help landing a date for the big day. A great outfit, flawless hair, and ... ashtray, they might as well resign themselves to a night at home with Rover. ...
(Date:2/13/2016)... ... ... individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and increased their ... delved into this niche allowing those giving up their beloved pasta a chance to ... of protein and only 7 grams of carbohydrates per 50 gram serving--a ratio that ...
(Date:2/13/2016)... FL (PRWEB) , ... February 13, 2016 , ... The ... environmental impact of American businesses. , The increasingly modern world of instantaneous consumption ... often on non-renewable energy sources such as oil and coal, which pollutes our air, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ) ... will ring the Nasdaq Closing Bell at the Nasdaq ... at 4:00 p.m. ET on Tuesday, February 16, ... Adrian Adams , will perform the honorary bell ... p.m. ET.  A live webcast will be available at: ...
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... research report titled Chronic Inflammation Global Clinical Trials ... snapshot of the global clinical trials landscape along ... trials by Region, Country (G7 & E7), Trial ... status and reviews top companies involved and enlists ...
(Date:2/11/2016)... Laboratory glassware and plasticware include ... may range from microscope slides to large storage boxes ... borosilicate glass because of its low weight and resistance ... started gaining popularity over the past decade when it ... with plastic in several applications due to its resistance ...
Breaking Medicine Technology: